Press Releases
Stay up to date with press releases covering announcements, company news, product launches, and business updates.
Publish your press release
Katie Baillio, Recognized by Influential Women, Opens Pathways to Employment for Rural and Justice-Involved Veterans
EIN Presswire
TX, UNITED STATES, November 13, 2026 /EINPresswire.com/ -- Rural Veterans Career Advisor at the Texas Veterans Commission, Katie Draws on Two Decades of U.S. Army Service and a Ph.D. in Human Services to Help Veterans Build Successful Civilian...
As Social and Mental Health Issues Grow, Nonprofit Urges Adoption of Kindness-Based HEART Programs as the Solution
EIN Presswire
Prevention, health, wellness start with kindness.
Detroit’s AI Recommendation Gap: 38% of U.S. Auto Sales, Just 11% of All Recommendation Points
EIN Presswire
New BrandRank.AI Automotive Index finds Toyota and Lexus dominating AI car recommendations as traditional U.S. automakers trail behind.
FDA Meeting Could Put NeOnc's NEO100 Experimental Brain Cancer Drug on Faster Track
GlobeNewswire, Inc.
DENVER, Nov. 11, 2026 (GLOBE NEWSWIRE) -- (247MarketNews) — NeOnc Technologies Holdings (NASDAQ: NTHI) secured a Type B End-of-Phase meeting, scheduled for early January 2027, with the U.S. Food and Drug Administration (FDA), to discuss a...
On Veterans Day, Governor Hochul Signs Legislation to Strengthen Support for New York's Veterans
New York State Office of the Governor
In honor of Veterans Day, Governor Kathy Hochul signed six pieces of legislation to strengthen support for New York's veterans, service members and military families.
From Boston to Portland: QuTEM and OHSU Give West Coast Advanced Therapy Developers a Direct Path from R&D to GMP
EIN Presswire
Collaboration with OHSU’s MMC in Portland brings faster, local TEM analysis of viral vectors and nanoparticles to West Coast Advanced Therapy developers.
Vistagen Provides Regulatory Update Following Productive Type C Meeting with U.S. FDA on Phase 3 Development of Fasedienol for Social Anxiety Disorder
GlobeNewswire, Inc.
SOUTH SAN FRANCISCO, Calif., Nov. 09, 2026 (GLOBE NEWSWIRE) -- Vistagen (Nasdaq: VTGN), a late clinical-stage biopharmaceutical company pioneering neuroscience with nose-to-brain neurocircuitry, today announced a regulatory update from its recent,...
Teva Shares Innovative Pipeline Updates and Unveils Path to Future Growth at R&D Day, Targeting $6–7 Billion in Innovative Medicines Revenue by 2030
GlobeNewswire, Inc.
The Company has more than doubled revenue from innovative medicines since launching Pivot to Growth in 2023, demonstrating sustained execution and the growing strength of its high-velocity biopharma model A live webcast of the event and...
J-Star Holding Co., Ltd. Highlights U.S. Operational Progress with Delegation Visit from Global Tier 1 Carbon Fiber Manufacturer
GlobeNewswire, Inc.
TAICHUNG, Taiwan and HOUSTON, Nov. 09, 2026 (GLOBE NEWSWIRE) -- J-Star Holding Co., Ltd. (Nasdaq: YMAT) (“J-Star” or the “Company”), an innovator in advanced composite manufacturing, today announced continued progress in advancing its U.S....
Milestone Scientific Reports Financial Results for Third Quarter 2026
GlobeNewswire, Inc.
Medical Segment Revenue Grows 136% Year-Over-Year Expands CompuFlo® Physician Partnerships and Advances Medical Commercialization Online Demonstrations More Than Double Reflecting Increased Customer Engagement Reaffirms 2026 Outlook for...
National NP Week Celebrates Nurse Practitioners as a Powerful Force in American Health Care
GlobeNewswire, Inc.
AUSTIN, TEXAS, Nov. 09, 2026 (GLOBE NEWSWIRE) -- Communities across the country are joining the American Association of Nurse Practitioners® (AANP) in celebrating National Nurse Practitioner Week, Nov. 8-14, recognizing the more than 461,000...
Beeline Medicines Announces Presentation of Phase 2 Results of Afimetoran in Systemic Lupus Erythematosus at ACR Convergence 2026
GlobeNewswire, Inc.
– All three afimetoran doses met the primary endpoint with a placebo-adjusted difference in SRI-4 response of more than 30 percentage points at Week 48 (p<0.001 for all doses) – – Secondary endpoints were directionally consistent with the primary...
A $400 Billion Healthcare Opportunity: Telehealth Companies Positioned to Capitalize on a Massive Industry Shift
GlobeNewswire, Inc.
NEW YORK, Nov. 11, 2026 (GLOBE NEWSWIRE) -- Healthcare is changing, and telehealth is becoming a bigger part of that shift.
Holiday Cash Volume: How Multi-Location Retailers Prepare
GlobeNewswire, Inc.
Miami, Florida, United States, Nov. 13, 2026 (GLOBE NEWSWIRE) -- For retailers and other businesses with many locations, the holiday season is a stress test for cash operations.
Ballipinar Dental Clinic to Bring Oral Health Advice to UK Patients During Mouth Cancer Action Month
GlobeNewswire, Inc.
LONDON, Nov. 11, 2026 (GLOBE NEWSWIRE) -- Ballipinar Dental Clinic is using this November's Mouth Cancer Action Month to encourage greater awareness of oral health warning signs among UK patients, ahead of its scheduled patient meet-ups in...
UPDATED -- Benitec Biopharma Releases First Quarter 2027 Fiscal-Year Financial Results and Provides Operational Update
GlobeNewswire, Inc.
Positive interim clinical results from the ongoing BB-301 Phase 1b/2a study for dysphagic patients with Oculopharyngeal Muscular Dystrophy (OPMD), presented as a late-breaking poster at the European Society of Gene and Cell Therapy (ESGCT) Annual...
Akara Raises $5.5M to Bring Privacy-Preserving AI to Hospitals
GlobeNewswire, Inc.
LOS ANGELES, Nov. 11, 2026 (GLOBE NEWSWIRE) -- Akara, a healthcare technology company developing AI for hospital operations, today announced $5.5 million in funding, bringing its total funding to $12.3 million.
Nurix Therapeutics Appoints Arati V. Rao, M.D., as Chief Medical Officer
GlobeNewswire, Inc.
BRISBANE, Calif., Nov. 11, 2026 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted protein degradation medicines, today...
Arvinas to Present at Jefferies Global Healthcare Conference
GlobeNewswire, Inc.
NEW HAVEN, Conn., Nov. 11, 2026 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, today announced that management will participate in a...
Gov. Kemp Announces 182 Appointments and Reappointments to Boards, Authorities, and Commissions
Georgia Office of the Governor
Atlanta, GA – Governor Brian P. Kemp today announced 182 appointments and reappointments to various state boards, authorities, and commissions.
Sign up for:
US Healthcare Journal
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.